- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Treatment with gonadotrophin releasing hormone (GnRH) agonist
- Meeting Date: July 2026
Triptorelin – July 2026
- Intramuscular (I.M.) injection 3.75 mg with solvent, syringe and needles
Public Summary Documents
Last updated
12 November 2026
